BRC Inc Class A BRCC 深 滬
已收盤 02-06 16:00:00 美东时间
0.8255
+0.086
+11.55%
華盛通- 最 高0.8277
- 今 開0.801
- 成交量 86.34万股
- 最 低 0.7501
- 昨 收 0.74
- 總市值 2.05亿
- 52周最高 2.775
- 市盈率 靜 --
- 換手率 0.35%
- 52周最低 0.732
- 委 比 0.00%
- 總股本 2.48亿
- 歷史最高 34.00
- 量 比 0.93
- 振 幅 10.49%
- 歷史最低 0.732
- 每 手 1
- 風險率 0.44%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元
01-15 16:10
Telsey Advisory Group Maintains Outperform on BRC, Maintains $2.5 Price Target
Telsey Advisory Group analyst Sarang Vora maintains BRC (NYSE:BRCC) with a Outperform and maintains $2.5 price target.
01-14 20:25
BRC FY2025 Revenue expected to be At least $395.000M vs $399.104M Est
BRC (NYSE:BRCC) FY2025 Revenue expected to be more than $395.000M vs $399.104M Est
2025-11-04 05:19
BRC Q3 Sales $100.712M Miss $101.791M Estimate
BRC (NYSE:BRCC) reported quarterly sales of $100.712 million which missed the analyst consensus estimate of $101.791 million by 1.06 percent. This is a 2.55 percent increase over sales of $98.204 million the same period
2025-11-04 05:17
美股大行评级 | 买入！Fermi、Neptune获多家大行首予评级；伯克希尔哈撒韦罕见地获得“卖出”评级；摩根大通上调苹果目标价升至290美元
今日重点评级关注：Guggenheim：上调Neumora Therapeutics评级至"买入"，目标价14美元；韦德布什：上调Fate Therapeutics评级至"跑赢大市"，目标价从5美元升至7美元
2025-10-28 10:08
Telsey Advisory Group Maintains Outperform on BRC, Maintains $2.5 Price Target
Telsey Advisory Group analyst Sarang Vora maintains BRC (NYSE:BRCC) with a Outperform and maintains $2.5 price target.
2025-10-27 18:36
BRC Expands Board, Appoints Melvin Landis
An update from BRC ( ($BRCC) ) is now available. On September 15, 2025, BRC Inc...
2025-09-17 20:48
Telsey Advisory Group Maintains Outperform on BRC, Maintains $4 Price Target
Telsey Advisory Group analyst Sarang Vora maintains BRC (NYSE:BRCC) with a Outperform and maintains $4 price target.
2025-08-05 18:24
